QT
DFTX

Quantbot Technologies’s Definium Therapeutics DFTX Stock Holding History

Quantbot Technologies’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$434K Buy
+9,230
New +$228K 0.02% 983
2026
Q1 		– Sell
-1,649
Closed -$22.1K – 1992
2025
Q4 		$22.1K Buy
+1,649
New +$20.4K ﹤0.01% 1563
2024
Q3 		– Sell
-1,577
Closed -$11.4K – 1693
2024
Q2 		$11.4K Buy
+1,577
New +$13.8K ﹤0.01% 1348

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Quantbot Technologies's DFTX Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 9,230 shares worth $434K. The stake represents 0.02% of the portfolio and ranks #983 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in DFTX as recently as Q4 2025.

Quantbot Technologies first reported a position in DFTX in Q2 2024 and has held it in 3 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Quantbot Technologies held 9,230 shares of Definium Therapeutics worth $434K as of Q2 2026.
  • Definium Therapeutics was a new Quantbot Technologies position in Q2 2026.
  • Definium Therapeutics made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #983 holding.
  • Quantbot Technologies first reported a position in Definium Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.